$BOOM

Full Transcript: DMC Glb Q1 2026 Earnings Call

DMC Global reported a 15% year-over-year decline in first-quarter consolidated sales to $135.6 million, with adjusted EBITDA of $3.9 million, primarily due to macroeconomic challenges and supply chain disruptions. Despite the downturn, the company's order backlog reached a 15-year high, signaling potential future growth. Management provided a second-quarter sales guidance of $148 to $158 million and adjusted EBITDA of $6 to $8 million, anticipating improvements across all business segments driven by stronger order activity and project shipments.

Original reporting
Benzinga · Benzinga Staff Writer
Published May 1, 2026, 7:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 8:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Full Transcript: DMC Glb Q1 2026 Earnings Call — source image
Decision brief

The 30-second read

$BOOMNeutralLow
01

Why it matters

Despite short-term setbacks, a high order backlog suggests resilience and potential for recovery.

02

Market read

The company's backlog growth may signal a positive long-term outlook, but short-term earnings decline tempers immediate optimism.

03

What to watch

Potential supply chain disruptions may persist, impacting future earnings.

Timing: short-term; upcoming quarterly results and backlog developments.

Background

DMC Global faced macroeconomic challenges and supply chain disruptions, leading to a 15% decline in Q1 sales.

Company-level read

Ticker impact

$BOOMNeutralMedium confidence
Context

Low relevance due to minimal impact on broader markets.

Expected impact

Limited immediate price movement; potential for upward trend if backlog translates into future revenue.

Evidence & confidence

The company's current decline is offset by a high backlog, indicating future potential. The low relevance score suggests limited immediate impact on BOOM's stock price.

Market effects

Potential positive signals for manufacturing and energy sectors due to backlog growth.

Limited; primarily affects company-specific outlook.

negligible; the news has minimal impact on global markets.

Counterpoint

The decline in sales could signal deeper macroeconomic issues affecting the sector.

Key entities

  • DMC Global

    A manufacturer involved in various sectors including energy, infrastructure, and manufacturing.

Related articles

$BOOMMedAI 8/10

DMC Global (BOOM) Q2 2026 Earnings Call Transcript

DMC Global (BOOM) reported Q2 revenue of $157.0 million, up 1% year over year and 16% sequentially, at the high end of its forecast. Adjusted EBITDA was $10.7 million, above the high end of its range. Net income rose to $0.10 per diluted share. Q3 guidance calls for revenue of $158 million to $168 million and adjusted EBITDA of $10 million to $13 million.

$BOOMMedAI 8/10

DMC Global Q2 Earnings Call Highlights

Still, Arcadia saw stronger turnover in its short-cycle products sold through regional service centers, as well as increased demand for high-end residential windows and doors. Management said the improvement reflected efforts to restore product availability and customer service after earlier supply-chain and product-availability issues.

$BOOMMed

DMC Global’s building products biz posts best quarter since 2024 – BizWest

BROOMFIELD — DMC Global Inc. (Nasdaq: BOOM), a Broomfield-based manufacturer of products for the energy, industrial and construction markets, posted second-quarter consolidated sales of $157 million. While that figure was roughly flat from the same period last year, Arcadia, DMC’s building products business, delivered its strongest sales performance since the second quarter of 2024. Adjusted EBITDA attributable to DMC was $10.7 million, down 21% year over year.

$BOOMMed

DMC Global Inc. (BOOM): Results of Operations and Financial Condition

DMC Global Inc. (BOOM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE: CONTACT: Geoff High, Vice President of Investor Relations 303-604-3924 DMC GLOBAL REPORTS SECOND QUARTER FINANCIAL RESULTS • Second quarter sales were $157.0 million • Net income attributable to DMC was $0.5 million, or $0.10 per diluted share

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.